Currently, for a lot of practitioners (hospital and liberals) and researchers (together with public well being), the WHO definition of well being is outdated: first it appears extra utopian than pragmatic; then, it proves unsuitable for a big half of the world inhabitants. There is clearly a necessity to refine this definition or suggest further standards to be extra related or discriminating.
In this angle, what can indigenous folks provide in the elaboration of a new definition of well being? In this text, leaders or representatives of autochthonous peoples, anthropologists and physicians from many cultural origins (Amazonia, Patagonia, Papua New-Guinea, Inuit, North-American Indian, sub-Saharan Africa, India, China, Melanesia and Polynesia) have tried to determine and clarify a number of key ideas that WHO ought to reintegrate into its new definition of well being: human equilibrium in nature, accepted spirituality and adaptation.
On the sidelines of the software of COP21 selections that ought to give again to man his place into the atmosphere, autochthonous folks leaders, anthropologists and MDs clarify why these three ideas are elementary and common well being determinants, and want to be included in a new WHO definition of well being.
A name for motion: Why anthropologists can (and ought to) be part of the dialogue on local weather change via schooling.
Anthropologists, human biologists, and researchers in associated fields have been investigating the human-environment interplay and its results on well being for many years. While there have been quite a few research from the medical- and health-sectors pointing to the connection between local weather change and well being wants, in addition to research advocating for the incorporation of acceptable curricula addressing these wants in medical colleges and health-professional packages, this connection just isn’t being systematically taught to our future healthcare professionals.
Here, we first briefly summarize analysis highlighting the interplay between atmosphere and well being; we comply with this with dialogue about why this interplay is necessary for present and future medical professionals to perceive, notably in mild of the present points of local weather change. We particularly handle how anthropologists and human biologists have contributed to the literature on marginal environments and local weather change, and how anthropological analysis could also be included in health-oriented and medical school rooms to assist on this dialogue.
Through interdisciplinary collaboration between anthropologists, human biologists, medical-health professionals, and researchers in different fields, we are able to study from our previous and play a component in piecing collectively our future well being care points and wants.
Accuracy Rates of Ancestry Estimation by Forensic Anthropologists Using Identified Forensic Cases.
A widespread process in forensic anthropology entails the estimation of the ancestry of a decedent by evaluating their skeletal morphology and measurements to skeletons of people from recognized geographic teams. However, the accuracy charges of ancestry estimation strategies in precise forensic casework have not often been studied. This article makes use of 99 forensic circumstances with recognized skeletal stays to develop accuracy charges for ancestry estimations performed by forensic anthropologists.
The total charge of right ancestry estimation from these circumstances is 90.9%, which is comparable to most research-derived charges and these reported by particular person practitioners. Statistical checks confirmed no vital distinction in accuracy charges relying on examiner schooling stage or on the estimated or recognized ancestry. More current circumstances confirmed a considerably larger accuracy charge. The incorporation of metric analyses into the ancestry estimate in these circumstances led to a better accuracy charge.
Anthropologists in Global Health Experiments.
Can international well being experiments be half of extra versatile programs of information technology, the place completely different our bodies of information come collectively to present understanding not solely of the outcomes of new interventions but in addition of the mechanisms via which they have an effect on folks’s well-being and well being? Building previous work by which they tried to remodel how international well being experiments are carried out and impressed by the articles on this particular concern, the authors of this commentary argue that strategic collaboration is required to break the hegemony of randomized managed trials in designing international well being applied sciences.
More open-ended experiments are potential if anthropologists crew up with revolutionary researchers in biomedicine to develop new conceptual fashions and to undertake novel observational strategies and ‘good’ trials that incorporate ethnography to unravel complicated interactions between native biologies, attributes of well being programs, social infrastructures, and customers’ on a regular basis lives.
Anthropologists handle well being fairness: recognizing boundaries to care.
Systems change is important for enhancing well being care in the United States, particularly for populations affected by well being disparities. Theoretical and methodological contributions of anthropology to well being care design and supply can inform programs change by offering a window into supplier and affected person perceptions and practices.
3,6-Dibenzyl-2-hydroxy-5-methoxypyrazine |
|||
TBW00480 | ChemNorm | unit | Ask for price |
Diphthalate Ester Std Dibenzyl phthalate Neat |
|||
REPHT089 | Scientific Laboratory Supplies | 10MG | EUR 86.17 |
Dibenzylamine |
|||
20-abx184670 | Abbexa |
|
|
Dibenzyldiselenide |
|||
20-abx185390 | Abbexa |
|
|
Dibenzylfluorescein |
|||
GW7767-100 | Glentham Life Sciences | 100 | EUR 300.9 |
Dibenzylfluorescein |
|||
GW7767-500 | Glentham Life Sciences | 500 | EUR 737 |
1,3:2,4-Dibenzylidene sorbitol |
|||
20-abx180956 | Abbexa |
|
|
Bis(dibenzylideneacetone)palladium(0) |
|||
20-abx182380 | Abbexa |
|
|
Bis(dibenzylideneacetone) palladium(0) |
|||
GX7504-1 | Glentham Life Sciences | 1 | EUR 135.6 |
Tris(dibenzylideneacetone)dipalladium(0) |
|||
20-abx184467 | Abbexa |
|
|
Dibenz(ah)anthracene |
|||
S-1205 | Scientific Laboratory Supplies | 1ML | EUR 84 |
Dibenz(ac)anthracene |
|||
S-3922 | Scientific Laboratory Supplies | 1ML | EUR 84 |
Tris-(dibenzylideneacetone)-dipalladium(O)-chloroform adduct |
|||
20-abx182701 | Abbexa |
|
|
PAH Std Dibenz(ac)anthracene 100ug/mL in Toluene |
|||
REPAH2001 | Scientific Laboratory Supplies | 1ML | EUR 297.68 |
PAH Std Dibenzo(ah)anthracene 2000ug/mL in Toluene |
|||
REPAH113 | Scientific Laboratory Supplies | 1ML | EUR 125.34 |
PAH Std Dibenz(ah)anthracene-d14 100ug/mL in Toluene |
|||
REPAH1110 | Scientific Laboratory Supplies | 1ML | EUR 224.56 |
PAH Std Dibenz(ah)anthracene-d14 100ug/mL in Isooctane |
|||
REPAH1109 | Scientific Laboratory Supplies | 1ML | EUR 224.56 |
Dibenzo(ah)pyrene |
|||
S-1190 | Scientific Laboratory Supplies | 1ML | EUR 886.8 |
Dibenzo(ai)pyrene |
|||
S-1195 | Scientific Laboratory Supplies | 1ML | EUR 378 |
Dibenzo(al)pyrene |
|||
S-1196 | Scientific Laboratory Supplies | 1ML | EUR 88.8 |
Dibenzo(ae)pyrene |
|||
S-1200 | Scientific Laboratory Supplies | 1ML | EUR 88.8 |
Dibenzofuran |
|||
20-abx182417 | Abbexa |
|
|
Dibenzofuran |
|||
S-1180 | Scientific Laboratory Supplies | 1ML | EUR 45.6 |
Dibenz(aj)acridine |
|||
S-1207 | Scientific Laboratory Supplies | 1ML | EUR 73.2 |
Dibenz(ah)acridine |
|||
S-1215 | Scientific Laboratory Supplies | 1ML | EUR 73.2 |
DIBENZO 18‐CROWN‐6‐ETHER |
|||
504003 | Survival Technologies | each | Ask for price |
Dibenzosuberone |
|||
20-abx182418 | Abbexa |
|
|
Dibenzoyl Thiamine |
|||
HY-B2212 | MedChemExpress | 100mg | EUR 142.8 |
Dibenzothiophene |
|||
B1727-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 129.6 |
Description: Dibenzothiophene (DBT) is a model compound for organic sulfur in fossil fuels. |
Dibenzothiophene |
|||
B1727-50 | ApexBio | 50 mg | EUR 153.6 |
Description: Dibenzothiophene (DBT) is a model compound for organic sulfur in fossil fuels. |
Dibenzothiophene |
|||
HY-B0973 | MedChemExpress | 5g | EUR 142.8 |
Dibenzothiophene |
|||
S-1185 | Scientific Laboratory Supplies | 1ML | EUR 84 |
Dibenzothiophene |
|||
GK5381-25 | Glentham Life Sciences | 25 | EUR 31.7 |
Dibenzothiophene |
|||
GK5381-5 | Glentham Life Sciences | 5 | EUR 16.4 |
Dibenzosuberenone |
|||
20-abx181259 | Abbexa |
|
|
(−)‐O,O′‐DIBENZOYL‐L‐TARTARIC ACID |
|||
604001 | Survival Technologies | each | Ask for price |
PAH Std Dibenz(aj)acridine 1000ug/mL in DCM |
|||
REPAH154 | Scientific Laboratory Supplies | 1ML | EUR 138.39 |
PAH Std Dibenz(aj)acridine 2000ug/mL in DCM |
|||
REPAH155 | Scientific Laboratory Supplies | 1ML | EUR 168.42 |
YO-01027 (Dibenzazepine, DBZ) |
|||
A4018-10 | ApexBio | 10 mg | EUR 393.6 |
Description: YO-01027, also known as dibenzazepine or DBZ, is a potent inhibitor of ?-secretase, a multisubunit aspartyl protease catalyzing the cleavage of numerous type I integral membrane proteins (such as amyloid precursor protein (APP) and Notch). |
YO-01027 (Dibenzazepine, DBZ) |
|||
A4018-25 | ApexBio | 25 mg | EUR 714 |
Description: YO-01027, also known as dibenzazepine or DBZ, is a potent inhibitor of ?-secretase, a multisubunit aspartyl protease catalyzing the cleavage of numerous type I integral membrane proteins (such as amyloid precursor protein (APP) and Notch). |
YO-01027 (Dibenzazepine, DBZ) |
|||
A4018-5 | ApexBio | 5 mg | EUR 240 |
Description: YO-01027, also known as dibenzazepine or DBZ, is a potent inhibitor of ?-secretase, a multisubunit aspartyl protease catalyzing the cleavage of numerous type I integral membrane proteins (such as amyloid precursor protein (APP) and Notch). |
YO-01027 (Dibenzazepine, DBZ) |
|||
A4018-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 351.6 |
Description: YO-01027, also known as dibenzazepine or DBZ, is a potent inhibitor of ?-secretase, a multisubunit aspartyl protease catalyzing the cleavage of numerous type I integral membrane proteins (such as amyloid precursor protein (APP) and Notch). |
YO-01027 (Dibenzazepine, DBZ) |
|||
A4018-50 | ApexBio | 50 mg | EUR 880.8 |
Description: YO-01027, also known as dibenzazepine or DBZ, is a potent inhibitor of ?-secretase, a multisubunit aspartyl protease catalyzing the cleavage of numerous type I integral membrane proteins (such as amyloid precursor protein (APP) and Notch). |
YO-01027 (Dibenzazepine, DBZ) |
|||
A4018-S | ApexBio | Evaluation Sample | EUR 97.2 |
Description: YO-01027, also known as dibenzazepine or DBZ, is a potent inhibitor of ?-secretase, a multisubunit aspartyl protease catalyzing the cleavage of numerous type I integral membrane proteins (such as amyloid precursor protein (APP) and Notch). |
SVOC Std Dibenzofuran 1000ug/mL in MeOH |
|||
RESVOC045 | Scientific Laboratory Supplies | 1ML | EUR 116.2 |
SVOC Std Dibenzofuran 2000ug/mL in MeOH |
|||
RESVOC046 | Scientific Laboratory Supplies | 1ML | EUR 138.39 |
Dibenzenesulfonimide |
|||
20-abx183979 | Abbexa |
|
|
PAH Std Dibenzo(ae)pyrene 200ug/mL in Toluene |
|||
REPAH2801 | Scientific Laboratory Supplies | 1ML | EUR 365.57 |
PAH Std Dibenzo(ah)pyrene 200ug/mL in Toluene |
|||
REPAH2802 | Scientific Laboratory Supplies | 1ML | EUR 365.57 |
PAH Std Dibenzo(ai)pyrene 200ug/mL in Toluene |
|||
REPAH2803 | Scientific Laboratory Supplies | 1ML | EUR 439.99 |
PAH Std Dibenzo(al)pyrene 200ug/mL in Toluene |
|||
REPAH2804 | Scientific Laboratory Supplies | 1ML | EUR 439.99 |
PAH Std Dibenzo(el)pyrene 200ug/mL in Toluene |
|||
REPAH2805 | Scientific Laboratory Supplies | 1ML | EUR 3719.65 |
3,29-Dibenzoyl rarounitriol |
|||
HY-N0357 | MedChemExpress | 10mg | EUR 531.6 |
PAH Std Dibenzo(ae)pyrene 1000ug/mL in DCM:Benzene (50:50) |
|||
REPAH156 | Scientific Laboratory Supplies | 1ML | EUR 101.84 |
PAH Std Dibenzo(ae)pyrene 2000ug/mL in DCM:Benzene (50:50) |
|||
REPAH157 | Scientific Laboratory Supplies | 1ML | EUR 133.17 |
3,29-Dibenzoyl rarounitriol |
|||
TBZ2480 | ChemNorm | 20mg | Ask for price |
PAH Std Dibenzo(gp)chrysene 200ug/mL in Toluene |
|||
REPAH3205 | Scientific Laboratory Supplies | 1ML | EUR 1869.62 |
PAH Std Dibenzo(aj)coronene 200ug/mL in Toluene |
|||
REPAH3603 | Scientific Laboratory Supplies | 1ML | EUR 1423.1 |
(2'R)-N-Benzoyl-2'-deoxy-2'-fluoro-2'-methylcytidine 3',5'-dibenzoate |
|||
20-abx181403 | Abbexa |
|
|
PAH Std Dibenzo(ai)pyrene-d14 100ug/mL in Toluene |
|||
REPAH1112 | Scientific Laboratory Supplies | 1ML | EUR 554.88 |
PAH Std Dibenzo(bghi)perylene 200ug/mL in Toluene |
|||
REPAH3402 | Scientific Laboratory Supplies | 1ML | EUR 3719.65 |
PAH Std Dibenzo(eghi)perylene 200ug/mL in Toluene |
|||
REPAH3403 | Scientific Laboratory Supplies | 1ML | EUR 3719.65 |
Diethyleneglycol dibenzoate |
|||
S-4207 | Scientific Laboratory Supplies | 1ML | EUR 84 |
Dibenzothiophene-4-Boronic Acid |
|||
abx188677-5g | Abbexa | 5 g | EUR 343.2 |
(+)‐DIBENZOYL‐D‐TARTARIC ACID MONOHYDRATE |
|||
604002 | Survival Technologies | each | Ask for price |
PAH Std Dibenzo(ae)fluoranthene 200ug/mL in Toluene |
|||
REPAH2502 | Scientific Laboratory Supplies | 1ML | EUR 1869.62 |
1000 ug/mL Dibenzothiophene in Toluene Volume: 1mL Ampule |
|||
S-1185-TOL | Scientific Laboratory Supplies | 1ML | EUR 147.6 |
2-Deoxy-2-Fluoro-Alpha-D-Arabinofuranosyl Bromide 3,5-Dibenzoate |
|||
abx188240-25g | Abbexa | 25 g | EUR 2614.8 |
Anthrone |
|||
20-abx186373 | Abbexa |
|
|
Anthrone |
|||
AB0088 | Bio Basic | 25g | EUR 86.1 |
Anthrone |
|||
GT1240-100G | Glentham Life Sciences | 100 g | EUR 170.4 |
Anthrone |
|||
GT1240-25G | Glentham Life Sciences | 25 g | EUR 84 |
Anthrone |
|||
GT1240-100 | Glentham Life Sciences | 100 | EUR 110.7 |
Anthrone |
|||
GT1240-25 | Glentham Life Sciences | 25 | EUR 39.4 |
3-hydroxy Anthranilic Acid |
|||
C5792-1000 | ApexBio | 1 g | EUR 224.4 |
Description: 3-Hydroxyanthranilic acid (3-HAA) is an intermediate in the metabolism of the amino acid tryptophan. 3-HAA is an aminobenzoic acid generated by substitution of benzoic acid at C-2 with an amine group and at C-3 by a hydroxy group. |
3-hydroxy Anthranilic Acid |
|||
C5792-500 | ApexBio | 500 mg | EUR 151.2 |
Description: 3-Hydroxyanthranilic acid (3-HAA) is an intermediate in the metabolism of the amino acid tryptophan. 3-HAA is an aminobenzoic acid generated by substitution of benzoic acid at C-2 with an amine group and at C-3 by a hydroxy group. |
Bacillus anthracis (Anthrax) antibody |
|||
10-B02A | Fitzgerald | 1 mg | EUR 567.6 |
Description: Mouse monoclonal Bacillus anthracis (Anthrax) antibody |
Bacillus anthracis (Anthrax) antibody |
|||
10-B02B | Fitzgerald | 1 mg | EUR 562.8 |
Description: Mouse monoclonal Bacillus anthracis (Anthrax) antibody |
Bacillus anthracis (Anthrax) antibody |
|||
10R-B106a | Fitzgerald | 1 mg | EUR 681.6 |
Description: Mouse monoclonal Bacillus anthracis (Anthrax) antibody |
Bacillus anthracis (Anthrax) antibody |
|||
10R-B106b | Fitzgerald | 1 mg | EUR 681.6 |
Description: Mouse monoclonal Bacillus anthracis (Anthrax) antibody |
Bacillus anthracis (Anthrax) antibody |
|||
10R-B106c | Fitzgerald | 1 mg | EUR 567.6 |
Description: Mouse monoclonal Bacillus anthracis (Anthrax) antibody |
Bacillus anthracis (Anthrax) antibody |
|||
10R-B106d | Fitzgerald | 1 mg | EUR 567.6 |
Description: Mouse monoclonal Bacillus anthracis (Anthrax) antibody |
Bacillus anthracis (Anthrax) antibody |
|||
10R-B106e | Fitzgerald | 1 mg | EUR 562.8 |
Description: Mouse monoclonal Bacillus anthracis (Anthrax) antibody |
Bacillus anthracis (Anthrax) antibody |
|||
10R-B106f | Fitzgerald | 1 mg | EUR 681.6 |
Description: Mouse monoclonal Bacillus anthracis (Anthrax) antibody |
Bacillus anthracis (Anthrax) antibody |
|||
20-BR04 | Fitzgerald | 500 ug | EUR 429.6 |
Description: Rabbit polyclonal Bacillus anthracis (Anthrax) antibody |
Bacillus anthracis (Anthrax) antibody (Spore) |
|||
10C-CR9004M3 | Fitzgerald | 100 ug | EUR 603.6 |
Description: Mouse monoclonal Bacillus anthracis (Anthrax) antibody (Spore) |
Bacillus anthracis (Anthrax) antibody (Spore) |
|||
10C-CR9004M4 | Fitzgerald | 100 ug | EUR 603.6 |
Description: Mouse monoclonal Bacillus anthracis (Anthrax) antibody (Spore) |
Bacillus anthracis (Anthrax) antibody (Spore) |
|||
10R-B108a | Fitzgerald | 1 mg | EUR 781.2 |
Description: Mouse monoclonal Bacillus anthracis (Anthrax) antibody (Spore) |
Bacillus anthracis (Anthrax) antibody (Spore) |
|||
10R-B108b | Fitzgerald | 1 mg | EUR 781.2 |
Description: Mouse monoclonal Bacillus anthracis (Anthrax) antibody (Spore) |
Rabbit Anti-human Anthrax Toxin Receptor 3, aff pure IgG #1 |
|||
ATR31-A | Alpha Diagnostics | 100 ug | EUR 578.4 |
Bacillus anthracis (Anthrax) antibody (Lethal Factor) |
|||
10-B03A | Fitzgerald | 1 mg | EUR 567.6 |
Description: Mouse monoclonal Bacillus anthracis (Anthrax) antibody (Lethal Factor) |
Bacillus anthracis (Anthrax) antibody (Lethal Factor) |
|||
10-B03B | Fitzgerald | 1 mg | EUR 567.6 |
Description: Mouse monoclonal Bacillus anthracis (Anthrax) antibody (Lethal Factor) |
Bacillus anthracis (Anthrax) antibody (Lethal Factor) |
|||
10R-B107a | Fitzgerald | 1 mg | EUR 681.6 |
Description: Mouse monoclonal Bacillus anthracis (Anthrax) antibody (Lethal Factor) |
Bacillus anthracis (Anthrax) antibody (Lethal Factor) |
|||
10R-B107b | Fitzgerald | 1 mg | EUR 567.6 |
Description: Mouse monoclonal Bacillus anthracis (Anthrax) antibody (Lethal Factor) |
Bacillus Anthracis (Anthrax) protein (Protective Antigen) |
|||
30R-AA015 | Fitzgerald | 100 ug | EUR 1191.6 |
Description: Purified recombinant Bacillus Anthracis (Anthrax) protein (Protective Antigen) |
Anthrance A |
|||
GW3595-1 | Glentham Life Sciences | 1 | EUR 1349.6 |
Anthrance A |
|||
GW3595-100 | Glentham Life Sciences | 100 | EUR 284.3 |
Bacillus anthracis (Anthrax) antibody (Protective Antigen) |
|||
10C-CR9004M1 | Fitzgerald | 100 ug | EUR 489.6 |
Description: Mouse monoclonal Bacillus anthracis (Anthrax) antibody (Protective Antigen) |
Bacillus anthracis (Anthrax) antibody (Protective Antigen) |
|||
10C-CR9004M2 | Fitzgerald | 100 ug | EUR 489.6 |
Description: Mouse monoclonal Bacillus anthracis (Anthrax) antibody (Protective Antigen) |
Rabbit Anti-B. Anthracis Lethal factor (LF) (C-terminal peptide) IgG#3 |
|||
LF13-A | Alpha Diagnostics | 100 ug | EUR 578.4 |
Anthracene, 99% |
|||
GK6811-100G | Glentham Life Sciences | 100 g | EUR 93.6 |
Anthracene, 99% |
|||
GK6811-250G | Glentham Life Sciences | 250 g | EUR 156 |
Anthracene, 99% |
|||
GK6811-25G | Glentham Life Sciences | 25 g | EUR 60 |
Anthracene, 99% |
|||
GK6811-500G | Glentham Life Sciences | 500 g | EUR 237.6 |
Anthracene |
|||
S-290 | Scientific Laboratory Supplies | 1ML | EUR 97.2 |
Anthracene, 99% |
|||
GK6811-100 | Glentham Life Sciences | 100 | EUR 47.4 |
Anthracene, 99% |
|||
GK6811-25 | Glentham Life Sciences | 25 | EUR 19.8 |
Anthracene, 99% |
|||
GK6811-250 | Glentham Life Sciences | 250 | EUR 98.8 |
Anthracene, 99% |
|||
GK6811-500 | Glentham Life Sciences | 500 | EUR 166 |
Human Anthrax toxin receptor 3 protein Control/blocking peptide # 1 |
|||
ATR31-P | Alpha Diagnostics | 100 ug | EUR 196.8 |
Anthrax PA Peptide |
|||
3411P | ProSci | 0.05 mg | EUR 197.7 |
Description: (IN) Anthrax PA peptide |
Benz(a)anthracene |
|||
S-425 | Scientific Laboratory Supplies | 1ML | EUR 44.4 |
Anthriscinol |
|||
TBZ30111 | ChemNorm | unit | Ask for price |
Anthrax LF Antibody |
|||
20-abx137198 | Abbexa |
|
|
Anthrax LF Antibody |
|||
abx137198-600l | Abbexa | 600 µl | EUR 2665.2 |
Anthrax PA Antibody |
|||
24269-100ul | SAB | 100ul | EUR 468 |
Anthrax PA Antibody |
|||
3411-002mg | ProSci | 0.02 mg | EUR 206.18 |
Description: Anthrax PA Antibody: Anthrax infection is initiated by the inhalation, ingestion, or cutaneous contact with Bacillus anthracis endospores. B. anthracis produces three polypeptides that comprise the anthrax toxin: protective antigen (PA), lethal factor (LF), and edema factor (EF). PA binds to two related proteins on the cell surface; these are termed tumor epithelial marker 8 (TEM8)/anthrax toxin receptor (ATR) and capillary morphogenesis protein 2 (CMG2), although it is still unclear which is physiologically relevant. Following PA binding to its receptor, PA is cleaved into two fragments by a furin-like protease. The bound fragment binds both LF and EF; the resulting complex is then endocytosed which allows the translocation of LF and EF into the cytoplasm. These toxins are usually sufficient to cause rapid cell death, and often the death of the organism. |
Anthrax PA Antibody |
|||
3411-01mg | ProSci | 0.1 mg | EUR 523.7 |
Description: Anthrax PA Antibody: Anthrax infection is initiated by the inhalation, ingestion, or cutaneous contact with Bacillus anthracis endospores. B. anthracis produces three polypeptides that comprise the anthrax toxin: protective antigen (PA), lethal factor (LF), and edema factor (EF). PA binds to two related proteins on the cell surface; these are termed tumor epithelial marker 8 (TEM8)/anthrax toxin receptor (ATR) and capillary morphogenesis protein 2 (CMG2), although it is still unclear which is physiologically relevant. Following PA binding to its receptor, PA is cleaved into two fragments by a furin-like protease. The bound fragment binds both LF and EF; the resulting complex is then endocytosed which allows the translocation of LF and EF into the cytoplasm. These toxins are usually sufficient to cause rapid cell death, and often the death of the organism. |
Anthraquinone |
|||
AB0087 | Bio Basic | 25g | EUR 73.57 |
Anthranilic acid |
|||
GK9102-100G | Glentham Life Sciences | 100 g | EUR 70.8 |
Anthranilic acid |
|||
GK9102-25G | Glentham Life Sciences | 25 g | EUR 54 |
Anthraquinone |
|||
HY-N0354 | MedChemExpress | 100mg | EUR 129.6 |
Anthracene-d10 |
|||
S-291 | Scientific Laboratory Supplies | 1ML | EUR 80.4 |
Anthraquinone |
|||
S-295 | Scientific Laboratory Supplies | 1ML | EUR 150 |
Anthraquinone |
|||
GL8529-100 | Glentham Life Sciences | 100 | EUR 41.9 |
Anthraquinone |
|||
GL8529-25 | Glentham Life Sciences | 25 | EUR 19.9 |
Anthranilic acid |
|||
GK9102-100 | Glentham Life Sciences | 100 | EUR 29.2 |
Anthranilic acid |
|||
GK9102-25 | Glentham Life Sciences | 25 | EUR 15.9 |
G. Pig anti-B. Anthracis Anthrax protective antigen 83 (PA83) recomb. Protein antiserum |
|||
PA19-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Rabbit Anti-B. Anthracis Anthrax protective antigen 83 (PA83) (C-terminal peptide) IgG |
|||
PA17-A | Alpha Diagnostics | 100 ug | EUR 578.4 |
9-Anthraldehyde |
|||
20-abx186669 | Abbexa |
|
|
Anthranilic Acid [BSA] |
|||
DAG3271 | Creative Diagnostics | 1mg | EUR 1450.8 |
Anthraflavic acid |
|||
HY-W006230 | MedChemExpress | 10mM/1mL | EUR 135.6 |
9-Anthraldehyde |
|||
GK5039-5 | Glentham Life Sciences | 5 | EUR 58.6 |
9-Anthraldehyde |
|||
GK5039-500 | Glentham Life Sciences | 500 | EUR 371.1 |
Dibekacin sulfate |
|||
GA4403-10MG | Glentham Life Sciences | 10 mg | EUR 274.8 |
Dibekacin sulfate |
|||
GA4403-10 | Glentham Life Sciences | 10 | EUR 197.7 |
AnthraxPA Antibody |
|||
20-abx137199 | Abbexa |
|
|
AnthraxPA Antibody |
|||
abx137199-600l | Abbexa | 600 µl | EUR 2665.2 |
B. Anthracis LF Antibody |
|||
abx021538-1mg | Abbexa | 1 mg | EUR 886.8 |
B. Anthracis PA Antibody |
|||
abx021540-1mg | Abbexa | 1 mg | EUR 878.4 |
B. Anthracis PA Antibody |
|||
abx021543-1mg | Abbexa | 1 mg | EUR 886.8 |
B. Anthracis PA Antibody |
|||
abx021544-1mg | Abbexa | 1 mg | EUR 886.8 |
B. Anthracis SA Antibody |
|||
abx021545-1mg | Abbexa | 1 mg | EUR 1312.8 |
B. Anthracis SA Antibody |
|||
abx021546-1mg | Abbexa | 1 mg | EUR 1312.8 |
B. Anthracis LF Antibody |
|||
abx021547-1mg | Abbexa | 1 mg | EUR 886.8 |
B. Anthracis PA Antibody |
|||
abx021549-1mg | Abbexa | 1 mg | EUR 878.4 |
MP Std Anthraquinone +283 to +286C |
|||
RMP284 | Scientific Laboratory Supplies | 1G | EUR 68.4 |
Rabbit Anti-B. Anthracis Anthrax protective antigen 83 (PA83) recomb. Protein antiserum |
|||
PA18-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
3-(β-D-Glucopyranosyloxy)-1,6-dihydroxy-2-methyl-9,10-anthracenedione |
|||
TBW00974 | ChemNorm | 10mg | Ask for price |
Bacillus anthracis PCR kit |
|||
PCR-H504-48D | Bioingentech | 50T | EUR 543.6 |
Bacillus anthracis PCR kit |
|||
PCR-H504-96D | Bioingentech | 100T | EUR 686.4 |
Bacillus anthracis RT PCR kit |
|||
RTq-H504-100D | Bioingentech | 100T | EUR 860.4 |
Bacillus anthracis RT PCR kit |
|||
RTq-H504-150D | Bioingentech | 150T | EUR 969.6 |
Bacillus anthracis RT PCR kit |
|||
RTq-H504-50D | Bioingentech | 50T | EUR 717.6 |
9,10-Anthracenedione |
|||
TRD0052 | ChemNorm | 10mg | Ask for price |
Cell wall, sermi pure (B. Anthracis) |
|||
CWBA-5 | Alpha Diagnostics | 5 mg | EUR 634.8 |
9-Anthracenemethanol |
|||
20-abx186657 | Abbexa |
|
|
1-Hydroxy anthraquinone |
|||
20-abx180182 | Abbexa |
|
|
Anthrax Edema Factor Peptide |
|||
3419P | ProSci | 0.05 mg | EUR 197.7 |
Description: (CT) Anthrax Edema Factor peptide |
QPCR Kit DNA Bacillus anthracis |
|||
MOL6382 | Scientific Laboratory Supplies | EACH | EUR 1045.79 |
QPCR Kit DNA Bacillus anthrMmix |
|||
MOL6384 | Scientific Laboratory Supplies | EACH | EUR 1333.02 |
PAH Std Anthracene 2000ug/mL in Toluene |
|||
REPAH102 | Scientific Laboratory Supplies | 1ML | EUR 110.98 |
PAH Std Benzo(a)anthracene 10ug/mL in MeCn |
|||
REPAH118 | Scientific Laboratory Supplies | 1ML | EUR 130.56 |
Anthrax Edema Factor Antibody |
|||
24273-100ul | SAB | 100ul | EUR 468 |
Anthrax protective Antigen |
|||
30R-AA014 | Fitzgerald | 100 ug | EUR 1164 |
Description: Purified recombinant Bacillus Anthrax protective Antigen |
Our community-engaged analysis groups conduct in-depth investigations of supplier perceptions of sufferers, typically uncovering gaps between affected person and supplier perceptions leading to the degradation of well being fairness. We current examples of tasks the place collaborations between anthropologists and well being professionals resulted in actionable knowledge on functioning and malfunctioning systemic momentum towards efforts to remove disparities and assist wellness.